Browse News
Filter News
Found 530,411 articles
-
Technology is constantly impacting and changing the way the world works. Greater technological innovations are not only changing the way business operate, but also have significant impact on employees.
-
The placenta, sometimes called afterbirth, is described as an organ that develops in the uterus during pregnancy. Although research has been conducted on placentas for decades, three important studies were recently published related to the science of the placenta.
-
The Boston area, specifically Cambridge, has the highest concentration of biopharma companies in the U.S. That is followed rather closely by the San Francisco Bay Area. Many states want to encourage life science development—the return on investment can be very high, and the jobs they create are o...
-
Recently, Jeffrey Dorfman, a professor of economics at The University of Georgia, wrote about his later father, Paul Crane Dorfman, who was an international banker, and on the business lessons he learned from him.
-
CAP Files Legal Brief Supporting Challenge to Correct Scheme for Setting Medicare Fees for Clinical Laboratory Tests
12/12/2018
The CAP argues the administration failed to follow congressional intent when establishing market-based payment reforms for clinical laboratory services.
-
NOVADIP BIOSCIENCES appoints Jeff Abbey as CEO
12/12/2018
NOVADIP BIOSCIENCES announces that Jeff Abbey will be appointed chief executive officer, effective early 2019, succeeding Jean-François Pollet.
-
Grasp Changing Trends and Seek Industry Prosperity: InnoPack China 2019 to Create Room for Innovation with Every Effort
12/12/2018
According to the Global Pharmaceutical Packaging issued by the research institution Freedonia, global pharmaceutical packaging demand is growing by 6% per year and is projected to reach USD112 billion market size in 2021.
-
GenSight Biologics Reports Sustained Quality of Life Improvements at Week 72 of Phase III REVERSE Clinical Trial of GS010 for the Treatment of Leber Hereditary Optic Neuropathy (LHON)
12/12/2018
Composite score and relevant sub-scores in the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) showed sustained improvements at Week 48 and Week 72
-
BerGenBio Presents Key Results From PhII Programme With Selective AXL Inhibitor Bemcentinib at DNB's 9th Annual Nordic Healthcare Conference
12/12/2018
Bemcentinib proof of concept clinical data as monotherapy and in combination confirms focus on lung cancer & leukaemia
-
It seems like every time we turned around this year, there was an exciting or—on a more visceral level, “Hey, that’s cool!” science story. Here’s a look at the top 9 really cool life science discoveries of the year, from outer space, to peanut allergies, to tortoise genomes.
-
A group of researchers from UCLA have developed a spray gel that contains immune-stimulating drugs. The gel was effective about 50 percent of the time in stimulating laboratory animals’ immune systems to stop cancer from recurring and inhibiting its metastases.
-
The Genome of Giant Tortoise "Lonesome George" Provides Clues to Longevity and Disease Resistance
12/11/2018
Researchers published an article in the journal Nature Ecology & Evolution that described preliminary findings of gene variants in George associated with a strong immune system, efficient DNA repair and cancer resistance. -
White Americans make up the vast majority of clinical trial participants, despite evidence that some cancers affect minority populations in greater numbers.
-
According to consultant firm Frost & Sullivan, artificial intelligence (AI) systems will be the next big players in both global healthcare and individual gene editing. By 2021, the firm predicts that AI will be responsible for 6.7 billion dollars in revenue.
-
As the Trump administration has continued to show its lack of financial support of scientific research using fetal tissue, the National Institutes of Health is setting aside $20 million to fund research that could develop alternatives to the use of embryonic tissue.
-
With the closure of another year just weeks ahead, this time of year is one that many people use to take a look behind and see what lessons were learned over the past 12 months. For the world of biopharma, it’s also important to see what lessons have been learned.
-
Christmas came a little early for St. Jude Children’s Research Hospital in the form of a $50 million contribution from pharma giant AbbVie – the largest single contribution made to the famed hospital.
-
WuXi Biologics and Oxford BioTherapeutics Expand Partnership With 5 More Antibody Compounds
12/11/2018
WuXi Biologics, a Shanghai, China-based contract research organization focused on biologics, announced it was expanding its existing collaboration and licensing deals with UK-based Oxford BioTherapeutics (OBT). -
Dinko Valerio offers wisdom garnered from a long career as a scientist, investor and entrepreneur.
-
DBM Corporation Inc., Announces FDA 510(k) Market Clearance for MIRACU PDO Threads in U.S Market
12/11/2018
DBM Corporation, Inc. announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for MIRACU PDO Threads, a huge accomplishment for the company, as it marks the first PDO thread to receive 510 (k) clearance in the U.S. market.